Uveitis - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Uveitis - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Uveitis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

Introduction

Uveitis Overview

Therapeutics Development

Pipeline Products for Uveitis - Overview

Pipeline Products for Uveitis - Comparative Analysis

Uveitis - Therapeutics under Development by Companies

Uveitis - Therapeutics under Investigation by Universities/Institutes

Uveitis Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Uveitis - Products under Development by Companies

Uveitis - Products under Investigation by Universities/Institutes

Uveitis - Companies Involved in Therapeutics Development

  • 2-BBB Medicines BV
  • AbbVie Inc.
  • Aciont Inc.
  • Aldeyra Therapeutics, Inc.
  • Apitope International NV
  • Astellas Pharma Inc.
  • Bausch & Lomb Incorporated
  • Bionomics Limited
  • Bristol-Myers Squibb Company
  • Can-Fite BioPharma Ltd.
  • Clearside BioMedical, Inc.
  • Effimune SAS
  • Endocyte, Inc.
  • Enzo Biochem, Inc.
  • EyeGate Pharmaceuticals, Inc.
  • HanAll Biopharma Co., Ltd.
  • Icon Bioscience, Inc.
  • Johnson & Johnson
  • Kineta, Inc.
  • Mitotech S.A.
  • Neuroptis Biotech
  • Novartis AG
  • Oculis ehf
  • OncoNOx ApS
  • Palatin Technologies, Inc.
  • Panoptes Pharma Ges.m.b.H.
  • Pfizer Inc.
  • Precision Ocular Ltd
  • pSivida Corp.
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • SynDevRx, Inc.
  • ThromboGenics NV
  • TxCell SA
  • Virogenomics BioDevelopment, Inc.

For more information visit http://www.researchandmarkets.com/research/fhsv8x/uveitis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs, Optical

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs, Optical